Details
Stereochemistry | RACEMIC |
Molecular Formula | C10H13N3O2 |
Molecular Weight | 207.2291 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)NCC1COC2=C(O1)C=CC=C2
InChI
InChIKey=HIUVKVDQFXDZHU-UHFFFAOYSA-N
InChI=1S/C10H13N3O2/c11-10(12)13-5-7-6-14-8-3-1-2-4-9(8)15-7/h1-4,7H,5-6H2,(H4,11,12,13)
Molecular Formula | C10H13N3O2 |
Molecular Weight | 207.2291 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14147778
The drug may be given orally initially
at a dose of 20 mg. daily and doubled every fourth day until an effect is obtained. Where more rapid effect is desired, a loading dose of 40 mg. may be used.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:29:41 GMT 2023
by
admin
on
Fri Dec 15 17:29:41 GMT 2023
|
Record UNII |
9V0MRL0R5Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C02CC03
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
||
|
WHO-VATC |
QC02CC03
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1346
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL76725
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
C073344
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
1826
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
2165-19-7
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
SUB07989MIG
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
GUANOXAN
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
16564
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
m5873
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000084476
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
DTXSID3046166
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
C174589
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
DB13211
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY | |||
|
9V0MRL0R5Y
Created by
admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |